Posters

Short and long term results of phacoemulsification cataract surgery on intraocular pressure in patients with pseudoexfoliative glaucoma

Poster Details

First Author: B.Solmaz TURKEY

Co Author(s):    G. Yalcinkaya   I. Pasaoglu   C. Altan   B. Basarir   N. Alagoz   T. Yasar     

Abstract Details

Purpose:

To eveluate the effect of phacoemulsification on intraocular pressure (IOP) in patients with pseudoexfoliative glaucoma

Setting:

Retrospective study

Methods:

Onehundredseventeen eyes from 105 patients (32 female, 73 male) who had pseudoexfoliative glaucoma and underwent phacoemulsification surgery and implantation of intraocular lenses in Beyoglu Eye Training and Research Hospital between January 2016-December 2017 were included. Patients who had a history of any other ophthalmic surgery were excluded. Paired t test was used to compare between preoperative and postoperative IOP and the number of antiglaucomatous molecule that patients used.

Results:

Mean age of patients was 73,2±8,8. The demographic distrubution of cataracts The Sixty two of patients had nuclear, cortical (2 eyes), corticonuclear (11 eyes), subcapsular (11 eyes), nuclear and subcapsular (23 eyes), mature cataract (8 eyes). While in 102 of eyes the preoperative IOPs were under control with the antiglaucomatous molecules, 5 patient have controlled IOP without medication and 10 patients have high IOP despite the antiglaucomatous molecules. Avarage follow-up time after phacoemulsification surgery was 19,6±10,7 (1-59) months. There was a significant difference in the best corrrected visual acuity between pre and post operatively (p<0,05). The means of IOPs on preoperative, postoperative 1st day, in the 3rd month, at the 1st year and the last visit were 15.37±4.49; 18.88±7.28; 13.54±3.71; 12.86±3.13 ve 13.91±4.09 mmHg respectively (p<0,05). The average number of antiglaucomatous molecule were 2.18±1.04; 1.82±1.03; 2.29±0.99; 2.28±1.07; 2.33±1.09 respectively (p>0,05). Postoperatively the IOP was under controlled without any antiglaucomatous molecule in 7 eyes on 1st day, in 5 eyes in the 3rd month, 7 eyes at the 1st year and 7 eyes at the last visit. During the follow-up 4 of eyes were underwent trabeculectomy surgery and 1 of them was treated with the XEN implant to reduce the IOP.

Conclusions:

Phacoemulsification surgery is likely a part of glaucoma treatment in eyes with pseudoexfoliative glaucoma. In our study, the IOP was reduced significantly at all of visits after phacoemulsification surgery in eyes with pseudoexfoliative glaucoma. Only in 5 eyes, additional glaucoma surgery was needed to reduce the IOP. Phacoemulsification surgery should be considered as a glaucoma surgery in pseudoexfoliative glaucoma

Financial Disclosure:

None